Annual report

Period2022-01-21 → 2023-01-20

Filed2023-04-17

StandardJapan GAAP

ConsolidatedYes

Data checks24 of 24 passed

Key figures · 148

Metric	Value	Period	Scope	Source row
Revenue	¥160.1bn	2022-01-21 → 2023-01-20	Cons.	Net sales
Revenue	¥162.6bn	2021-01-21 → 2022-01-20	Cons.	Net sales
Revenue	¥158.2bn	2020-01-21 → 2021-01-20^d	Cons.	Net sales (5-year summary)
Revenue	¥168.3bn	2019-01-21 → 2020-01-20^d	Cons.	Net sales (5-year summary)
Revenue	¥171.6bn	2018-01-21 → 2019-01-20^d	Cons.	Net sales (5-year summary)
Operating income	¥707m	2022-01-21 → 2023-01-20	Cons.	Operating income
Operating income	¥4.6bn	2021-01-21 → 2022-01-20	Cons.	Operating income
Ordinary income	¥591m	2022-01-21 → 2023-01-20	Cons.	Ordinary income
Ordinary income	¥5.7bn	2021-01-21 → 2022-01-20	Cons.	Ordinary income
Ordinary income	¥5.7bn	2020-01-21 → 2021-01-20^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥2.9bn	2019-01-21 → 2020-01-20^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥6.0bn	2018-01-21 → 2019-01-20^d	Cons.	Ordinary income loss (5-year summary)
Profit before tax	¥1.1bn	2022-01-21 → 2023-01-20	Cons.	Income before income taxes
Profit before tax	¥5.7bn	2021-01-21 → 2022-01-20	Cons.	Income before income taxes
Net income (owners)	−¥507m	2022-01-21 → 2023-01-20	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥4.0bn	2021-01-21 → 2022-01-20	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥3.2bn	2020-01-21 → 2021-01-20^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥1.8bn	2019-01-21 → 2020-01-20^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥3.9bn	2018-01-21 → 2019-01-20^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income	−¥490m	2022-01-21 → 2023-01-20	Cons.	Profit loss
Net income	¥3.9bn	2021-01-21 → 2022-01-20	Cons.	Profit loss
Total assets	¥164.2bn	at 2023-01-20	Cons.	Assets
Total assets	¥159.0bn	at 2022-01-20	Cons.	Assets
Total assets	¥157.6bn	at 2021-01-20^d	Cons.	Total assets (5-year summary)
Total assets	¥163.4bn	at 2020-01-20^d	Cons.	Total assets (5-year summary)
Total assets	¥171.6bn	at 2019-01-20^d	Cons.	Total assets (5-year summary)
Total liabilities	¥80.1bn	at 2023-01-20	Cons.	Liabilities
Total liabilities	¥75.7bn	at 2022-01-20	Cons.	Liabilities
Net assets / equity	¥84.1bn	at 2023-01-20	Cons.	Net assets
Net assets / equity	¥83.3bn	at 2022-01-20	Cons.	Net assets
Net assets / equity	¥82.6bn	at 2021-01-20^d	Cons.	Net assets
Net assets / equity	¥89.2bn	at 2020-01-20^d	Cons.	Net assets (5-year summary)
Net assets / equity	¥93.9bn	at 2019-01-20^d	Cons.	Net assets (5-year summary)
Cash and deposits	¥27.2bn	at 2023-01-20	Cons.	Cash and deposits
Cash and deposits	¥27.6bn	at 2022-01-20	Cons.	Cash and deposits
Cash & equivalents	¥29.2bn	at 2023-01-20	Cons.	Cash and cash equivalents
Cash & equivalents	¥30.1bn	at 2022-01-20	Cons.	Cash and cash equivalents
Cash & equivalents	¥32.7bn	at 2021-01-20^d	Cons.	Cash and cash equivalents
Cash & equivalents	¥30.3bn	at 2020-01-20^d	Cons.	Cash and cash equivalents (5-year summary)
Cash & equivalents	¥38.4bn	at 2019-01-20^d	Cons.	Cash and cash equivalents (5-year summary)
Operating cash flow	¥5.1bn	2022-01-21 → 2023-01-20	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥8.1bn	2021-01-21 → 2022-01-20	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥12.5bn	2020-01-21 → 2021-01-20^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥11.5bn	2019-01-21 → 2020-01-20^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥10.9bn	2018-01-21 → 2019-01-20^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Investing cash flow	−¥5.0bn	2022-01-21 → 2023-01-20	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥6.5bn	2021-01-21 → 2022-01-20	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥7.6bn	2020-01-21 → 2021-01-20^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥15.5bn	2019-01-21 → 2020-01-20^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥16.9bn	2018-01-21 → 2019-01-20^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Financing cash flow	−¥1.1bn	2022-01-21 → 2023-01-20	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥3.7bn	2021-01-21 → 2022-01-20	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥2.3bn	2020-01-21 → 2021-01-20^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥4.1bn	2019-01-21 → 2020-01-20^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥2.6bn	2018-01-21 → 2019-01-20^d	Cons.	Net cash provided by used in financing activities (5-year summary)
EPS (basic)	¥-32.4	2022-01-21 → 2023-01-20	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥254.2	2021-01-21 → 2022-01-20	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥201.31	2020-01-21 → 2021-01-20^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥108	2019-01-21 → 2020-01-20^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥234.15	2018-01-21 → 2019-01-20^d	Cons.	Basic earnings loss per share (5-year summary)
Net assets per share	¥5,327.58	at 2023-01-20	Cons.	Net assets per share (5-year summary)
Net assets per share	¥5,290.73	at 2022-01-20	Cons.	Net assets per share (5-year summary)
Net assets per share	¥5,224.46	at 2021-01-20^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥5,341.36	at 2020-01-20^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥5,628.56	at 2019-01-20^d	Cons.	Net assets per share (5-year summary)
Equity ratio	50.9%	at 2023-01-20	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	52.1%	at 2022-01-20	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	51.8%	at 2021-01-20^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	53.9%	at 2020-01-20^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	54.0%	at 2019-01-20^d	Cons.	Equity to asset ratio (5-year summary)
ROE	-0.6%	2022-01-21 → 2023-01-20	Cons.	Rate of return on equity (5-year summary)
ROE	4.8%	2021-01-21 → 2022-01-20	Cons.	Rate of return on equity (5-year summary)
ROE	3.8%	2020-01-21 → 2021-01-20^d	Cons.	Rate of return on equity (5-year summary)
ROE	2.0%	2019-01-21 → 2020-01-20^d	Cons.	Rate of return on equity (5-year summary)
ROE	4.2%	2018-01-21 → 2019-01-20^d	Cons.	Rate of return on equity (5-year summary)
Employees	4,122	at 2023-01-20	Cons.	Number of employees
Employees	4,029	at 2022-01-20	Cons.	Number of employees
Employees	3,922	at 2021-01-20^d	Cons.	Number of employees
Employees	4,160	at 2020-01-20^d	Cons.	Number of employees
Employees	3,912	at 2019-01-20^d	Cons.	Number of employees
Revenue	¥5.0bn	2022-01-21 → 2023-01-20	Standalone	Operating revenue1
Revenue	¥4.8bn	2021-01-21 → 2022-01-20	Standalone	Operating revenue1
Revenue	¥4.8bn	2020-01-21 → 2021-01-20^d	Standalone	Operating revenue1 (5-year summary)
Revenue	¥6.6bn	2019-01-21 → 2020-01-20^d	Standalone	Operating revenue1 (5-year summary)
Revenue	¥9.2bn	2018-01-21 → 2019-01-20^d	Standalone	Operating revenue1 (5-year summary)
Operating income	¥1.7bn	2022-01-21 → 2023-01-20	Standalone	Operating income
Operating income	¥1.8bn	2021-01-21 → 2022-01-20	Standalone	Operating income
Ordinary income	¥2.3bn	2022-01-21 → 2023-01-20	Standalone	Ordinary income
Ordinary income	¥2.4bn	2021-01-21 → 2022-01-20	Standalone	Ordinary income
Ordinary income	¥1.9bn	2020-01-21 → 2021-01-20^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥4.0bn	2019-01-21 → 2020-01-20^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥6.8bn	2018-01-21 → 2019-01-20^d	Standalone	Ordinary income loss (5-year summary)
Profit before tax	¥2.8bn	2022-01-21 → 2023-01-20	Standalone	Income before income taxes
Profit before tax	¥2.2bn	2021-01-21 → 2022-01-20	Standalone	Income before income taxes
Net income	¥1.9bn	2022-01-21 → 2023-01-20	Standalone	Profit loss
Net income	¥1.4bn	2021-01-21 → 2022-01-20	Standalone	Profit loss
Net income	¥899m	2020-01-21 → 2021-01-20^d	Standalone	Net income loss (5-year summary)
Net income	¥2.4bn	2019-01-21 → 2020-01-20^d	Standalone	Net income loss (5-year summary)
Net income	¥5.8bn	2018-01-21 → 2019-01-20^d	Standalone	Net income loss (5-year summary)
Total assets	¥122.7bn	at 2023-01-20	Standalone	Assets
Total assets	¥122.2bn	at 2022-01-20	Standalone	Assets
Total assets	¥116.8bn	at 2021-01-20^d	Standalone	Total assets (5-year summary)
Total assets	¥119.1bn	at 2020-01-20^d	Standalone	Total assets (5-year summary)
Total assets	¥118.4bn	at 2019-01-20^d	Standalone	Total assets (5-year summary)
Total liabilities	¥42.3bn	at 2023-01-20	Standalone	Liabilities
Total liabilities	¥42.1bn	at 2022-01-20	Standalone	Liabilities
Net assets / equity	¥80.5bn	at 2023-01-20	Standalone	Net assets
Net assets / equity	¥80.1bn	at 2022-01-20	Standalone	Net assets
Net assets / equity	¥78.5bn	at 2021-01-20^d	Standalone	Net assets
Net assets / equity	¥84.7bn	at 2020-01-20^d	Standalone	Net assets (5-year summary)
Net assets / equity	¥86.3bn	at 2019-01-20^d	Standalone	Net assets (5-year summary)
Cash and deposits	¥21.1bn	at 2023-01-20	Standalone	Cash and deposits
Cash and deposits	¥21.3bn	at 2022-01-20	Standalone	Cash and deposits
EPS (basic)	¥122.15	2022-01-21 → 2023-01-20	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥91.77	2021-01-21 → 2022-01-20	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥56.51	2020-01-21 → 2021-01-20^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥147.92	2019-01-21 → 2020-01-20^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥350.21	2018-01-21 → 2019-01-20^d	Standalone	Basic earnings loss per share (5-year summary)
Dividend per share	¥60	2022-01-21 → 2023-01-20	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥60	2021-01-21 → 2022-01-20	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥60	2020-01-21 → 2021-01-20^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥60	2019-01-21 → 2020-01-20^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥60	2018-01-21 → 2019-01-20^d	Standalone	Dividend paid per share (5-year summary)
Net assets per share	¥5,128.06	at 2023-01-20	Standalone	Net assets per share (5-year summary)
Net assets per share	¥5,118.19	at 2022-01-20	Standalone	Net assets per share (5-year summary)
Net assets per share	¥5,025.94	at 2021-01-20^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥5,141.6	at 2020-01-20^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥5,239.52	at 2019-01-20^d	Standalone	Net assets per share (5-year summary)
Equity ratio	65.6%	at 2023-01-20	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	65.6%	at 2022-01-20	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	67.2%	at 2021-01-20^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	71.1%	at 2020-01-20^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	72.9%	at 2019-01-20^d	Standalone	Equity to asset ratio (5-year summary)
ROE	2.4%	2022-01-21 → 2023-01-20	Standalone	Rate of return on equity (5-year summary)
ROE	1.8%	2021-01-21 → 2022-01-20	Standalone	Rate of return on equity (5-year summary)
ROE	1.1%	2020-01-21 → 2021-01-20^d	Standalone	Rate of return on equity (5-year summary)
ROE	2.8%	2019-01-21 → 2020-01-20^d	Standalone	Rate of return on equity (5-year summary)
ROE	7.0%	2018-01-21 → 2019-01-20^d	Standalone	Rate of return on equity (5-year summary)
Shares issued	16,568,000	at 2023-01-20	Standalone	Total number of issued shares (5-year summary)
Shares issued	16,568,000	at 2022-01-20	Standalone	Total number of issued shares (5-year summary)
Shares issued	16,568,000	at 2021-01-20^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	16,568,000	at 2020-01-20^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	16,568,000	at 2019-01-20^d	Standalone	Total number of issued shares (5-year summary)
Employees	26	at 2023-01-20	Standalone	Number of employees
Employees	23	at 2022-01-20	Standalone	Number of employees
Employees	19	at 2021-01-20^d	Standalone	Number of employees
Employees	21	at 2020-01-20^d	Standalone	Number of employees
Employees	26	at 2019-01-20^d	Standalone	Number of employees

Periods use the dates stated in the filing. ^d = earlier-year period dated by calendar; ^v = that date confirmed by the company's own earlier filing.

Segments · 93

Segment	Item	Period	Value
Reconciling Itemsreconciling	capex	2022-01-21 → 2023-01-20	¥1.5bn
Reconciling Itemsreconciling	depreciation	2022-01-21 → 2023-01-20	¥373m
Reconciling Itemsreconciling	revenue	2022-01-21 → 2023-01-20	−¥636m
Reconciling Itemsreconciling	revenue intersegment	2022-01-21 → 2023-01-20	−¥636m
Reconciling Itemsreconciling	segment assets	at 2023-01-20	¥47.8bn
Reconciling Itemsreconciling	segment profit	2022-01-21 → 2023-01-20	−¥1.6bn
Domestic Beverage Businessreportable segment	capex	2022-01-21 → 2023-01-20	¥8.3bn
Domestic Beverage Businessreportable segment	depreciation	2022-01-21 → 2023-01-20	¥4.6bn
Domestic Beverage Businessreportable segment	employees	at 2023-01-20	2806 pure
Domestic Beverage Businessreportable segment	revenue	2022-01-21 → 2023-01-20	¥109.8bn
Domestic Beverage Businessreportable segment	revenue external	2022-01-21 → 2023-01-20	¥109.7bn
Domestic Beverage Businessreportable segment	revenue intersegment	2022-01-21 → 2023-01-20	¥25m
Domestic Beverage Businessreportable segment	segment assets	at 2023-01-20	¥60.4bn
Domestic Beverage Businessreportable segment	segment profit	2022-01-21 → 2023-01-20	¥2.8bn
Dy Do Pharmareportable segment	capex	2022-01-21 → 2023-01-20	¥1m
Dy Do Pharmareportable segment	depreciation	2022-01-21 → 2023-01-20	¥2m
Dy Do Pharmareportable segment	employees	at 2023-01-20	12 pure
Dy Do Pharmareportable segment	segment assets	at 2023-01-20	¥1.1bn
Dy Do Pharmareportable segment	segment profit	2022-01-21 → 2023-01-20	−¥499m
Food Businessreportable segment	capex	2022-01-21 → 2023-01-20	¥877m
Food Businessreportable segment	depreciation	2022-01-21 → 2023-01-20	¥848m
Food Businessreportable segment	employees	at 2023-01-20	254 pure
Food Businessreportable segment	revenue	2022-01-21 → 2023-01-20	¥19.6bn
Food Businessreportable segment	revenue external	2022-01-21 → 2023-01-20	¥19.6bn
Food Businessreportable segment	revenue intersegment	2022-01-21 → 2023-01-20	¥8m
Food Businessreportable segment	segment assets	at 2023-01-20	¥21.8bn
Food Businessreportable segment	segment profit	2022-01-21 → 2023-01-20	¥765m
International Beverage Businessreportable segment	capex	2022-01-21 → 2023-01-20	¥522m
International Beverage Businessreportable segment	depreciation	2022-01-21 → 2023-01-20	¥718m
International Beverage Businessreportable segment	employees	at 2023-01-20	706 pure
International Beverage Businessreportable segment	revenue	2022-01-21 → 2023-01-20	¥18.9bn
International Beverage Businessreportable segment	revenue external	2022-01-21 → 2023-01-20	¥18.9bn
International Beverage Businessreportable segment	segment assets	at 2023-01-20	¥13.5bn
International Beverage Businessreportable segment	segment profit	2022-01-21 → 2023-01-20	−¥1.1bn
Pharmaceutical Related Businessreportable segment	capex	2022-01-21 → 2023-01-20	¥220m
Pharmaceutical Related Businessreportable segment	depreciation	2022-01-21 → 2023-01-20	¥1.2bn
Pharmaceutical Related Businessreportable segment	employees	at 2023-01-20	318 pure
Pharmaceutical Related Businessreportable segment	revenue	2022-01-21 → 2023-01-20	¥12.5bn
Pharmaceutical Related Businessreportable segment	revenue external	2022-01-21 → 2023-01-20	¥11.9bn
Pharmaceutical Related Businessreportable segment	revenue intersegment	2022-01-21 → 2023-01-20	¥601m
Pharmaceutical Related Businessreportable segment	segment assets	at 2023-01-20	¥19.7bn
Pharmaceutical Related Businessreportable segment	segment profit	2022-01-21 → 2023-01-20	¥347m
—segment total	capex	2022-01-21 → 2023-01-20	¥9.9bn
—segment total	depreciation	2022-01-21 → 2023-01-20	¥7.4bn
—segment total	revenue	2022-01-21 → 2023-01-20	¥160.8bn
—segment total	revenue external	2022-01-21 → 2023-01-20	¥160.1bn
—segment total	revenue intersegment	2022-01-21 → 2023-01-20	¥636m
—segment total	segment assets	at 2023-01-20	¥116.4bn
—segment total	segment profit	2022-01-21 → 2023-01-20	¥2.3bn
Reconciling Itemsreconciling	capex	2021-01-21 → 2022-01-20	¥864m
Reconciling Itemsreconciling	depreciation	2021-01-21 → 2022-01-20	¥386m
Reconciling Itemsreconciling	revenue	2021-01-21 → 2022-01-20	−¥553m
Reconciling Itemsreconciling	revenue intersegment	2021-01-21 → 2022-01-20	−¥553m
Reconciling Itemsreconciling	segment assets	at 2022-01-20	¥50.5bn
Reconciling Itemsreconciling	segment profit	2021-01-21 → 2022-01-20	−¥1.5bn
Domestic Beverage Businessreportable segment	capex	2021-01-21 → 2022-01-20	¥7.4bn
Domestic Beverage Businessreportable segment	depreciation	2021-01-21 → 2022-01-20	¥4.0bn
Domestic Beverage Businessreportable segment	revenue	2021-01-21 → 2022-01-20	¥118.1bn
Domestic Beverage Businessreportable segment	revenue external	2021-01-21 → 2022-01-20	¥118.0bn
Domestic Beverage Businessreportable segment	revenue intersegment	2021-01-21 → 2022-01-20	¥40m
Domestic Beverage Businessreportable segment	segment assets	at 2022-01-20	¥57.8bn
Domestic Beverage Businessreportable segment	segment profit	2021-01-21 → 2022-01-20	¥6.3bn
Dy Do Pharmareportable segment	capex	2021-01-21 → 2022-01-20	¥6m
Dy Do Pharmareportable segment	depreciation	2021-01-21 → 2022-01-20	¥1m
Dy Do Pharmareportable segment	segment assets	at 2022-01-20	¥27m
Dy Do Pharmareportable segment	segment profit	2021-01-21 → 2022-01-20	−¥573m
Food Businessreportable segment	capex	2021-01-21 → 2022-01-20	¥755m
Food Businessreportable segment	depreciation	2021-01-21 → 2022-01-20	¥815m
Food Businessreportable segment	revenue	2021-01-21 → 2022-01-20	¥21.2bn
Food Businessreportable segment	revenue external	2021-01-21 → 2022-01-20	¥21.1bn
Food Businessreportable segment	revenue intersegment	2021-01-21 → 2022-01-20	¥17m
Food Businessreportable segment	segment assets	at 2022-01-20	¥20.6bn
Food Businessreportable segment	segment profit	2021-01-21 → 2022-01-20	¥959m
International Beverage Businessreportable segment	capex	2021-01-21 → 2022-01-20	¥995m
International Beverage Businessreportable segment	depreciation	2021-01-21 → 2022-01-20	¥496m
International Beverage Businessreportable segment	revenue	2021-01-21 → 2022-01-20	¥12.8bn
International Beverage Businessreportable segment	revenue external	2021-01-21 → 2022-01-20	¥12.8bn
International Beverage Businessreportable segment	segment assets	at 2022-01-20	¥9.6bn
International Beverage Businessreportable segment	segment profit	2021-01-21 → 2022-01-20	−¥528m
Pharmaceutical Related Businessreportable segment	capex	2021-01-21 → 2022-01-20	¥223m
Pharmaceutical Related Businessreportable segment	depreciation	2021-01-21 → 2022-01-20	¥1.2bn
Pharmaceutical Related Businessreportable segment	revenue	2021-01-21 → 2022-01-20	¥11.1bn
Pharmaceutical Related Businessreportable segment	revenue external	2021-01-21 → 2022-01-20	¥10.6bn
Pharmaceutical Related Businessreportable segment	revenue intersegment	2021-01-21 → 2022-01-20	¥494m
Pharmaceutical Related Businessreportable segment	segment assets	at 2022-01-20	¥20.4bn
Pharmaceutical Related Businessreportable segment	segment profit	2021-01-21 → 2022-01-20	−¥19m
—segment total	capex	2021-01-21 → 2022-01-20	¥9.4bn
—segment total	depreciation	2021-01-21 → 2022-01-20	¥6.5bn
—segment total	revenue	2021-01-21 → 2022-01-20	¥163.2bn
—segment total	revenue external	2021-01-21 → 2022-01-20	¥162.6bn
—segment total	revenue intersegment	2021-01-21 → 2022-01-20	¥553m
—segment total	segment assets	at 2022-01-20	¥108.5bn
—segment total	segment profit	2021-01-21 → 2022-01-20	¥6.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,730

Item	Context	Value	Unit
Non audit fees consolidated subsidiaries network firms	Prior1YearDuration	－	JPY
Audit fees consolidated subsidiaries network firms	CurrentYearDuration	6000000	JPY
Non audit fees consolidated subsidiaries network firms	CurrentYearDuration	6000000	JPY
Audit fees total network firms	Prior1YearDuration	4000000	JPY
Non audit fees total network firms	Prior1YearDuration	6000000	JPY
Audit fees total network firms	CurrentYearDuration	6000000	JPY
Non audit fees total network firms	CurrentYearDuration	6000000	JPY
Total amount of remuneration etc remuneration etc by category of directors and other officers	CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember	179000000	JPY
Base remuneration remuneration etc by category of directors and other officers	CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember	129000000	JPY
Performance linked bonus remuneration by category of directors and other officers	CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember	38000000	JPY
Restricted share awards remuneration etc by category of directors and other officers	CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember	2000000	JPY
Trust type stock compensation remuneration by category of directors and other officers	CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember	8000000	JPY
Number of directors and other officers remuneration etc by category of directors and other officers	CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember	3
Total amount of remuneration etc remuneration etc by category of directors and other officers	CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember	15000000	JPY
Base remuneration remuneration etc by category of directors and other officers	CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember	15000000	JPY
Performance linked bonus remuneration by category of directors and other officers	CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember	－	JPY
Restricted share awards remuneration etc by category of directors and other officers	CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember	－	JPY
Trust type stock compensation remuneration by category of directors and other officers	CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember	－	JPY
Number of directors and other officers remuneration etc by category of directors and other officers	CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember	1
Total amount of remuneration etc remuneration etc by category of directors and other officers	CurrentYearDuration_OutsideDirectorsMember	23000000	JPY
Base remuneration remuneration etc by category of directors and other officers	CurrentYearDuration_OutsideDirectorsMember	23000000	JPY
Performance linked bonus remuneration by category of directors and other officers	CurrentYearDuration_OutsideDirectorsMember	－	JPY
Restricted share awards remuneration etc by category of directors and other officers	CurrentYearDuration_OutsideDirectorsMember	－	JPY
Trust type stock compensation remuneration by category of directors and other officers	CurrentYearDuration_OutsideDirectorsMember	－	JPY
Number of directors and other officers remuneration etc by category of directors and other officers	CurrentYearDuration_OutsideDirectorsMember	4
Total amount of remuneration etc remuneration etc by category of directors and other officers	CurrentYearDuration_OutsideCorporateAuditorsMember	12000000	JPY
Base remuneration remuneration etc by category of directors and other officers	CurrentYearDuration_OutsideCorporateAuditorsMember	12000000	JPY
Performance linked bonus remuneration by category of directors and other officers	CurrentYearDuration_OutsideCorporateAuditorsMember	－	JPY
Restricted share awards remuneration etc by category of directors and other officers	CurrentYearDuration_OutsideCorporateAuditorsMember	－	JPY
Trust type stock compensation remuneration by category of directors and other officers	CurrentYearDuration_OutsideCorporateAuditorsMember	－	JPY
Number of directors and other officers remuneration etc by category of directors and other officers	CurrentYearDuration_OutsideCorporateAuditorsMember	3
Total amount of remuneration etc paid by group remuneration etc paid by group to each director or other officer	CurrentYearDuration_jpcrp030000-asr_E00424-000TakamatsuTomiyaMember	160000000	JPY
Number of issues shares not listed investment shares held for purposes other than pure investment reporting company	CurrentYearInstant	14
Carrying amount shares not listed investment shares held for purposes other than pure investment reporting company	CurrentYearInstant	131000000	JPY
Number of issues shares other than those not listed investment shares held for purposes other than pure investment reporting company	CurrentYearInstant	12
Carrying amount shares other than those not listed investment shares held for purposes other than pure investment reporting company	CurrentYearInstant	8794000000	JPY
Number of issues whose number of shares increased shares not listed investment shares held for purposes other than pure investment reporting company	CurrentYearDuration	－
Total acquisition cost for increased shares shares not listed investment shares held for purposes other than pure investment reporting company	CurrentYearDuration	－	JPY
Number of issues whose number of shares increased shares other than those not listed investment shares held for purposes other than pure investment reporting company	CurrentYearDuration	1
Total acquisition cost for increased shares shares other than those not listed investment shares held for purposes other than pure investment reporting company	CurrentYearDuration	0	JPY
Number of issues whose number of shares decreased shares not listed investment shares held for purposes other than pure investment reporting company	CurrentYearDuration	1
Total sale amount for decreased shares shares not listed investment shares held for purposes other than pure investment reporting company	CurrentYearDuration	0	JPY
Number of issues whose number of shares decreased shares other than those not listed investment shares held for purposes other than pure investment reporting company	CurrentYearDuration	3
Total sale amount for decreased shares shares other than those not listed investment shares held for purposes other than pure investment reporting company	CurrentYearDuration	807000000	JPY
Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company	CurrentYearInstant_Row1Member	8411216
Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company	Prior1YearInstant_Row1Member	9593216
Book value details of specified investment equity securities held for purposes other than pure investment reporting company	CurrentYearInstant_Row1Member	6273000000	JPY
Book value details of specified investment equity securities held for purposes other than pure investment reporting company	Prior1YearInstant_Row1Member	7794000000	JPY
Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company	CurrentYearInstant_Row2Member	544000
Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company	Prior1YearInstant_Row2Member	544000

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed

balance sheet identity	consolidated 2022-01-20	pass rounding
balance sheet identity	consolidated 2023-01-20	pass
balance sheet identity	non_consolidated 2022-01-20	pass rounding
balance sheet identity	non_consolidated 2023-01-20	pass
dei present		pass
period resolution		pass
statement vs summary · net assets	consolidated 2021-01-20	pass
statement vs summary · net assets	consolidated 2022-01-20	pass
statement vs summary · net assets	consolidated 2023-01-20	pass
statement vs summary · net assets	non_consolidated 2021-01-20	pass
statement vs summary · net assets	non_consolidated 2022-01-20	pass
statement vs summary · net assets	non_consolidated 2023-01-20	pass
statement vs summary · net income attributable to parent	consolidated 2021-01-21/2022-01-20	pass
statement vs summary · net income attributable to parent	consolidated 2022-01-21/2023-01-20	pass
statement vs summary · operating cash flow	consolidated 2021-01-21/2022-01-20	pass
statement vs summary · operating cash flow	consolidated 2022-01-21/2023-01-20	pass
statement vs summary · revenue	consolidated 2021-01-21/2022-01-20	pass
statement vs summary · revenue	consolidated 2022-01-21/2023-01-20	pass
statement vs summary · revenue	non_consolidated 2021-01-21/2022-01-20	pass
statement vs summary · revenue	non_consolidated 2022-01-21/2023-01-20	pass
statement vs summary · total assets	consolidated 2022-01-20	pass
statement vs summary · total assets	consolidated 2023-01-20	pass
statement vs summary · total assets	non_consolidated 2022-01-20	pass
statement vs summary · total assets	non_consolidated 2023-01-20	pass